BMY logo

Bristol-Myers Squibb (BMY) Operating profit

annual operating profit:

$5.89B-$2.31B(-28.16%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BMY annual operating income is $5.89 billion, with the most recent change of -$2.31 billion (-28.16%) on December 1, 2024.
  • During the last 3 years, BMY annual operating profit has fallen by -$2.65 billion (-31.04%).
  • BMY annual operating profit is now -35.34% below its all-time high of $9.10 billion, reached on December 31, 2022.

Performance

BMY Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

quarterly operating profit:

$510.00M-$1.66B(-76.52%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BMY quarterly operating income is $510.00 million, with the most recent change of -$1.66 billion (-76.52%) on December 1, 2024.
  • Over the past year, BMY quarterly operating profit has dropped by -$1.39 billion (-73.20%).
  • BMY quarterly operating profit is now -80.89% below its all-time high of $2.67 billion, reached on March 31, 2022.

Performance

BMY quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

TTM operating profit:

$5.89B-$1.39B(-19.13%)
December 1, 2024

Summary

  • As of today (April 16, 2025), BMY TTM operating income is $5.89 billion, with the most recent change of -$1.39 billion (-19.13%) on December 1, 2024.
  • Over the past year, BMY TTM operating profit has dropped by -$2.31 billion (-28.16%).
  • BMY TTM operating profit is now -39.62% below its all-time high of $9.75 billion, reached on September 30, 2022.

Performance

BMY TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

BMY Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.2%-73.2%-28.2%
3 y3 years-31.0%-73.2%-28.2%
5 y5 years-0.4%-73.2%-28.2%

BMY Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.3%at low-80.9%at low-39.6%at low
5 y5-year-35.3%+170.4%-80.9%+160.8%-39.6%+170.4%
alltimeall time-35.3%+443.6%-80.9%+108.9%-39.6%+253.8%

Bristol-Myers Squibb Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$5.89B(-28.2%)
$510.00M(-76.5%)
$5.89B(-19.1%)
Sep 2024
-
$2.17B(+28.4%)
$7.28B(+3.0%)
Jun 2024
-
$1.69B(+11.7%)
$7.07B(-2.9%)
Mar 2024
-
$1.51B(-20.4%)
$7.28B(-11.2%)
Dec 2023
$8.20B(-10.0%)
$1.90B(-2.9%)
$8.20B(+2.6%)
Sep 2023
-
$1.96B(+3.1%)
$7.99B(-1.7%)
Jun 2023
-
$1.90B(-21.8%)
$8.13B(-8.4%)
Mar 2023
-
$2.43B(+43.6%)
$8.87B(-2.6%)
Dec 2022
$9.10B(+6.6%)
$1.69B(-19.3%)
$9.10B(-6.6%)
Sep 2022
-
$2.10B(-20.6%)
$9.75B(+0.8%)
Jun 2022
-
$2.64B(-1.0%)
$9.67B(+3.2%)
Mar 2022
-
$2.67B(+14.1%)
$9.37B(+9.8%)
Dec 2021
$8.54B(+292.1%)
$2.34B(+15.9%)
$8.54B(+59.3%)
Sep 2021
-
$2.02B(-13.9%)
$5.36B(+14.5%)
Jun 2021
-
$2.34B(+27.8%)
$4.68B(+45.0%)
Mar 2021
-
$1.83B(-318.6%)
$3.23B(+48.3%)
Dec 2020
$2.18B(-63.2%)
-$839.00M(-162.5%)
$2.18B(-39.1%)
Sep 2020
-
$1.34B(+50.6%)
$3.58B(-10.4%)
Jun 2020
-
$891.00M(+13.8%)
$3.99B(-19.8%)
Mar 2020
-
$783.00M(+39.8%)
$4.98B(-15.8%)
Dec 2019
$5.91B(+15.6%)
$560.00M(-68.2%)
$5.91B(-14.5%)
Sep 2019
-
$1.76B(-6.2%)
$6.92B(+1.5%)
Jun 2019
-
$1.88B(+9.2%)
$6.82B(+25.0%)
Mar 2019
-
$1.72B(+9.9%)
$5.45B(+6.6%)
Dec 2018
$5.11B(+48.4%)
$1.56B(-5.8%)
$5.11B(+25.9%)
Sep 2018
-
$1.66B(+223.4%)
$4.06B(+21.1%)
Jun 2018
-
$513.00M(-62.8%)
$3.35B(-5.5%)
Mar 2018
-
$1.38B(+170.4%)
$3.55B(+3.0%)
Dec 2017
$3.45B(-22.9%)
$510.00M(-46.4%)
$3.45B(-10.2%)
Sep 2017
-
$951.00M(+34.1%)
$3.84B(-8.7%)
Jun 2017
-
$709.00M(-44.4%)
$4.20B(-9.2%)
Mar 2017
-
$1.28B(+41.5%)
$4.63B(+3.6%)
Dec 2016
$4.47B(+158.2%)
$902.00M(-31.5%)
$4.47B(+30.1%)
Sep 2016
-
$1.32B(+15.8%)
$3.43B(+25.6%)
Jun 2016
-
$1.14B(+2.1%)
$2.73B(+58.9%)
Mar 2016
-
$1.11B(-949.6%)
$1.72B(-0.5%)
Dec 2015
$1.73B(+0.9%)
-$131.00M(-121.3%)
$1.73B(-7.0%)
Sep 2015
-
$616.00M(+400.8%)
$1.86B(-4.5%)
Jun 2015
-
$123.00M(-89.0%)
$1.95B(-8.3%)
Mar 2015
-
$1.12B(<-9900.0%)
$2.12B(+23.9%)
Dec 2014
$1.71B(-41.5%)
-$1.00M(-100.1%)
$1.71B(-33.5%)
Sep 2014
-
$703.00M(+135.1%)
$2.58B(-3.1%)
Jun 2014
-
$299.00M(-58.1%)
$2.66B(-11.0%)
Mar 2014
-
$713.00M(-17.3%)
$2.99B(+2.0%)
Dec 2013
$2.93B(-25.5%)
$862.00M(+9.7%)
$2.93B(+13.0%)
Sep 2013
-
$786.00M(+25.2%)
$2.59B(+9.7%)
Jun 2013
-
$628.00M(-4.1%)
$2.36B(-13.8%)
Mar 2013
-
$655.00M(+25.0%)
$2.74B(-30.2%)
Dec 2012
$3.93B(-40.8%)
$524.00M(-5.9%)
$3.93B(-21.0%)
Sep 2012
-
$557.00M(-44.7%)
$4.98B(-19.2%)
Jun 2012
-
$1.01B(-45.3%)
$6.16B(-10.6%)
Mar 2012
-
$1.84B(+17.5%)
$6.89B(+3.8%)
Dec 2011
$6.64B(+11.5%)
$1.57B(-9.9%)
$6.64B(+2.8%)
Sep 2011
-
$1.74B(+0.2%)
$6.46B(+2.7%)
Jun 2011
-
$1.74B(+9.2%)
$6.29B(+3.7%)
Mar 2011
-
$1.59B(+14.6%)
$6.06B(+1.9%)
Dec 2010
$5.95B(+9.4%)
$1.39B(-11.6%)
$5.95B(-3.8%)
Sep 2010
-
$1.57B(+3.9%)
$6.18B(+2.1%)
Jun 2010
-
$1.51B(+2.2%)
$6.05B(+2.2%)
Mar 2010
-
$1.48B(-8.7%)
$5.92B(+8.9%)
Dec 2009
$5.44B(+8.3%)
$1.62B(+12.3%)
$5.44B(+0.4%)
Sep 2009
-
$1.44B(+4.4%)
$5.42B(+4.4%)
Jun 2009
-
$1.38B(+38.7%)
$5.19B(+1.9%)
Mar 2009
-
$996.00M(-37.7%)
$5.10B(-1.7%)
Dec 2008
$5.02B(+42.4%)
$1.60B(+31.5%)
$5.19B(+10.8%)
Sep 2008
-
$1.22B(-5.4%)
$4.68B(+7.8%)
Jun 2008
-
$1.28B(+18.3%)
$4.34B(+11.1%)
Mar 2008
-
$1.09B(-0.6%)
$3.91B(+8.3%)
Dec 2007
$3.53B(+47.9%)
$1.09B(+24.5%)
$3.61B(+44.6%)
Sep 2007
-
$878.00M(+3.2%)
$2.50B(+20.2%)
Jun 2007
-
$851.00M(+8.4%)
$2.08B(-7.9%)
Mar 2007
-
$785.00M(-4231.6%)
$2.25B(-5.5%)
Dec 2006
$2.39B(-36.2%)
-$19.00M(-104.1%)
$2.39B(-21.2%)
Sep 2006
-
$458.00M(-55.5%)
$3.03B(-14.7%)
Jun 2006
-
$1.03B(+12.3%)
$3.55B(-2.6%)
Mar 2006
-
$917.00M(+47.4%)
$3.64B(-2.5%)
DateAnnualQuarterlyTTM
Dec 2005
$3.74B(-16.3%)
$622.00M(-36.5%)
$3.74B(-9.2%)
Sep 2005
-
$980.00M(-12.8%)
$4.12B(-4.5%)
Jun 2005
-
$1.12B(+11.2%)
$4.31B(-0.5%)
Mar 2005
-
$1.01B(+1.0%)
$4.33B(-3.0%)
Dec 2004
$4.46B(-9.5%)
$1.00B(-14.6%)
$4.46B(-3.4%)
Sep 2004
-
$1.17B(+2.2%)
$4.62B(-4.6%)
Jun 2004
-
$1.15B(+0.3%)
$4.84B(-2.1%)
Mar 2004
-
$1.14B(-1.1%)
$4.95B(+0.3%)
Dec 2003
$4.93B(+20.3%)
$1.16B(-17.1%)
$4.93B(+10.5%)
Sep 2003
-
$1.40B(+11.4%)
$4.46B(+7.7%)
Jun 2003
-
$1.25B(+10.9%)
$4.14B(+10.7%)
Mar 2003
-
$1.13B(+64.1%)
$3.74B(-8.7%)
Dec 2002
$4.10B(-20.5%)
$688.00M(-36.0%)
$4.10B(-4.6%)
Sep 2002
-
$1.07B(+26.2%)
$4.30B(-9.2%)
Jun 2002
-
$852.00M(-42.7%)
$4.74B(-11.7%)
Mar 2002
-
$1.49B(+67.7%)
$5.36B(-2.3%)
Dec 2001
$5.16B(-13.8%)
$886.00M(-41.4%)
$5.49B(-11.6%)
Sep 2001
-
$1.51B(+2.4%)
$6.21B(-0.2%)
Jun 2001
-
$1.48B(-8.3%)
$6.22B(-0.4%)
Mar 2001
-
$1.61B(+0.2%)
$6.24B(+1.3%)
Dec 2000
$5.99B(+14.3%)
$1.61B(+5.2%)
$6.16B(+3.7%)
Sep 2000
-
$1.53B(+1.9%)
$5.95B(+3.2%)
Jun 2000
-
$1.50B(-2.0%)
$5.76B(+3.2%)
Mar 2000
-
$1.53B(+10.2%)
$5.58B(+1.0%)
Dec 1999
$5.24B(+17.6%)
$1.39B(+3.5%)
$5.53B(+15.3%)
Sep 1999
-
$1.34B(+1.8%)
$4.79B(-0.1%)
Jun 1999
-
$1.32B(-10.7%)
$4.79B(+3.3%)
Mar 1999
-
$1.48B(+125.7%)
$4.64B(+4.1%)
Dec 1998
$4.46B(+0.4%)
$654.00M(-51.4%)
$4.46B(-8.7%)
Sep 1998
-
$1.35B(+15.6%)
$4.88B(+3.2%)
Jun 1998
-
$1.16B(-9.9%)
$4.73B(+2.9%)
Mar 1998
-
$1.29B(+20.0%)
$4.60B(+3.6%)
Dec 1997
$4.44B(+12.3%)
$1.08B(-9.9%)
$4.44B(+3.0%)
Sep 1997
-
$1.20B(+15.9%)
$4.31B(+3.3%)
Jun 1997
-
$1.03B(-8.9%)
$4.17B(+2.7%)
Mar 1997
-
$1.13B(+19.5%)
$4.06B(+2.8%)
Dec 1996
$3.95B(+9.3%)
$948.00M(-10.6%)
$3.95B(+2.2%)
Sep 1996
-
$1.06B(+14.8%)
$3.87B(+2.7%)
Jun 1996
-
$923.00M(-9.7%)
$3.77B(+1.6%)
Mar 1996
-
$1.02B(+18.4%)
$3.71B(+2.5%)
Dec 1995
$3.62B(+12.2%)
$863.00M(-9.9%)
$3.62B(+3.3%)
Sep 1995
-
$958.00M(+11.1%)
$3.50B(+2.5%)
Jun 1995
-
$862.00M(-7.5%)
$3.42B(+2.7%)
Mar 1995
-
$932.00M(+24.6%)
$3.33B(+3.2%)
Dec 1994
$3.22B(+34.0%)
$748.00M(-14.4%)
$3.22B(+25.3%)
Sep 1994
-
$874.00M(+13.2%)
$2.57B(+2.0%)
Jun 1994
-
$772.00M(-6.8%)
$2.52B(+2.8%)
Mar 1994
-
$828.00M(+744.9%)
$2.45B(+2.1%)
Dec 1993
$2.40B(+22.6%)
$98.00M(-88.1%)
$2.40B(+18.0%)
Sep 1993
-
$823.00M(+16.9%)
$2.04B(+0.7%)
Jun 1993
-
$704.00M(-9.5%)
$2.02B(+1.8%)
Mar 1993
-
$778.00M(-390.3%)
$1.99B(+1.4%)
Dec 1992
$1.96B(-29.1%)
-$268.00M(-133.2%)
$1.96B(-30.3%)
Sep 1992
-
$808.00M(+20.8%)
$2.81B(+0.9%)
Jun 1992
-
$669.00M(-10.9%)
$2.79B(-0.9%)
Mar 1992
-
$751.00M(+28.8%)
$2.81B(+1.7%)
Dec 1991
$2.77B(+15.8%)
$583.00M(-25.6%)
$2.77B(+4.2%)
Sep 1991
-
$784.00M(+12.8%)
$2.65B(+2.6%)
Jun 1991
-
$695.00M(-1.3%)
$2.59B(+3.6%)
Mar 1991
-
$704.00M(+49.2%)
$2.50B(+4.6%)
Dec 1990
$2.39B(+120.6%)
$472.00M(-34.1%)
$2.39B(-162.4%)
Sep 1990
-
$716.00M(+18.2%)
-$3.83B(+72.1%)
Jun 1990
-
$606.00M(+1.8%)
-$2.23B(+279.0%)
Mar 1990
-
$595.00M(-110.4%)
-$587.00M(-154.2%)
Dec 1989
$1.08B(-38.8%)
-$5.75B(-347.7%)
$1.08B(-50.4%)
Sep 1989
-
$2.32B(+3.4%)
$2.19B(+6.0%)
Jun 1989
-
$2.24B(-0.9%)
$2.06B(+7.5%)
Mar 1989
-
$2.27B(-148.8%)
$1.92B(+8.4%)
Dec 1988
$1.77B(+20.7%)
-$4.64B(-311.5%)
$1.77B(-20.0%)
Sep 1988
-
$2.20B(+4.5%)
$2.21B(+16.1%)
Jun 1988
-
$2.10B(-0.8%)
$1.91B(+12.5%)
Mar 1988
-
$2.12B(-150.4%)
$1.69B(+15.5%)
Dec 1987
$1.47B
-$4.20B(-322.4%)
$1.47B(-74.1%)
Sep 1987
-
$1.89B(0.0%)
$5.67B(+50.0%)
Jun 1987
-
$1.89B(0.0%)
$3.78B(+100.0%)
Mar 1987
-
$1.89B
$1.89B

FAQ

  • What is Bristol-Myers Squibb annual operating income?
  • What is the all time high annual operating profit for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual operating profit year-on-year change?
  • What is Bristol-Myers Squibb quarterly operating income?
  • What is the all time high quarterly operating profit for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly operating profit year-on-year change?
  • What is Bristol-Myers Squibb TTM operating income?
  • What is the all time high TTM operating profit for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM operating profit year-on-year change?

What is Bristol-Myers Squibb annual operating income?

The current annual operating profit of BMY is $5.89B

What is the all time high annual operating profit for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual operating income is $9.10B

What is Bristol-Myers Squibb annual operating profit year-on-year change?

Over the past year, BMY annual operating income has changed by -$2.31B (-28.16%)

What is Bristol-Myers Squibb quarterly operating income?

The current quarterly operating profit of BMY is $510.00M

What is the all time high quarterly operating profit for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly operating income is $2.67B

What is Bristol-Myers Squibb quarterly operating profit year-on-year change?

Over the past year, BMY quarterly operating income has changed by -$1.39B (-73.20%)

What is Bristol-Myers Squibb TTM operating income?

The current TTM operating profit of BMY is $5.89B

What is the all time high TTM operating profit for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM operating income is $9.75B

What is Bristol-Myers Squibb TTM operating profit year-on-year change?

Over the past year, BMY TTM operating income has changed by -$2.31B (-28.16%)
On this page